Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

RAPH

Raphael Pharmaceutical (QB) (RAPH)

Raphael Pharmaceutical Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:RAPH
DatumZeitQuelleÜberschriftSymbolFirma
04/06/202422h22Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:RAPHRaphael Pharmaceutical Inc (QB)
23/05/202422h16Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:RAPHRaphael Pharmaceutical Inc (QB)
09/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RAPHRaphael Pharmaceutical Inc (QB)
14/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
14/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
01/06/202317h57Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
01/06/202317h56Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
25/05/202322h34Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
15/05/202322h45Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
04/05/202322h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
24/03/202314h13Edgar (US Regulatory)Annual Report (10-k)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
13/03/202321h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
13/03/202321h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
26/01/202312h04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
14/11/202217h53Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
24/10/202222h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RAPHRaphael Pharmaceutical Inc (QB)
 Showing the most relevant articles for your search:USOTC:RAPH